157 related articles for article (PubMed ID: 37191188)
1. Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system.
Barry A; Samuel SF; Hosni I; Moursi A; Feugere L; Sennett CJ; Deepak S; Achawal S; Rajaraman C; Iles A; Wollenberg Valero KC; Scott IS; Green V; Stead LF; Greenman J; Wade MA; Beltran-Alvarez P
Lab Chip; 2023 May; 23(11):2664-2682. PubMed ID: 37191188
[TBL] [Abstract][Full Text] [Related]
2. Arginine methylation: the promise of a 'silver bullet' for brain tumours?
Samuel SF; Barry A; Greenman J; Beltran-Alvarez P
Amino Acids; 2021 Apr; 53(4):489-506. PubMed ID: 33404912
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line.
Samuel SF; Marsden AJ; Deepak S; Rivero F; Greenman J; Beltran-Alvarez P
Proteomes; 2018 Oct; 6(4):. PubMed ID: 30347783
[TBL] [Abstract][Full Text] [Related]
4. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
5. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.
Bryant JP; Heiss J; Banasavadi-Siddegowda YK
Cells; 2021 Jan; 10(1):. PubMed ID: 33440687
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
Wang SM; Dowhan DH; Muscat GEO
J Mol Endocrinol; 2019 Apr; 62(3):R223-R237. PubMed ID: 30620710
[TBL] [Abstract][Full Text] [Related]
8. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Al-Hamashi AA; Diaz K; Huang R
Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Arginine Methylation Impairs Platelet Function.
Marsden AJ; Riley DRJ; Barry A; Khalil JS; Guinn BA; Kemp NT; Rivero F; Beltran-Alvarez P
ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1567-1577. PubMed ID: 34661075
[TBL] [Abstract][Full Text] [Related]
10. Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.
Kölbel K; Ihling C; Bellmann-Sickert K; Neundorf I; Beck-Sickinger AG; Sinz A; Kühn U; Wahle E
J Biol Chem; 2009 Mar; 284(13):8274-82. PubMed ID: 19158082
[TBL] [Abstract][Full Text] [Related]
11. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
[TBL] [Abstract][Full Text] [Related]
12. A systematic survey of PRMT interactomes reveals the key roles of arginine methylation in the global control of RNA splicing and translation.
Wei HH; Fan XJ; Hu Y; Tian XX; Guo M; Mao MW; Fang ZY; Wu P; Gao SX; Peng C; Yang Y; Wang Z
Sci Bull (Beijing); 2021 Jul; 66(13):1342-1357. PubMed ID: 36654156
[TBL] [Abstract][Full Text] [Related]
13. The regulation, functions and clinical relevance of arginine methylation.
Guccione E; Richard S
Nat Rev Mol Cell Biol; 2019 Oct; 20(10):642-657. PubMed ID: 31350521
[TBL] [Abstract][Full Text] [Related]
14. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
[TBL] [Abstract][Full Text] [Related]
15. Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies.
Sauter C; Simonet J; Guidez F; Dumétier B; Pernon B; Callanan M; Bastie JN; Aucagne R; Delva L
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358861
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
17. Arginine methylation of a mitochondrial guide RNA binding protein from Trypanosoma brucei.
Pelletier M; Xu Y; Wang X; Zahariev S; Pongor S; Aletta JM; Read LK
Mol Biochem Parasitol; 2001 Nov; 118(1):49-59. PubMed ID: 11704273
[TBL] [Abstract][Full Text] [Related]
18. PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
Jarrold J; Davies CC
Trends Mol Med; 2019 Nov; 25(11):993-1009. PubMed ID: 31230909
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and Inhibitors of Histone Arginine Methylation.
Fulton MD; Brown T; Zheng YG
Chem Rec; 2018 Dec; 18(12):1792-1807. PubMed ID: 30230223
[TBL] [Abstract][Full Text] [Related]
20. Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions.
Tong C; Chang X; Qu F; Bian J; Wang J; Li Z; Xu X
Eur J Med Chem; 2024 Mar; 267():116212. PubMed ID: 38359536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
